Below is a comprehensive archive of press releases from MSF-USA. Use the options in the boxes below to filter results based on your preferences.

Country/Region

Topic

April 26, 2017

The current outbreak of hepatitis E in Diffa, Niger, highlights the poor water and sanitation conditions in which the vast majority of the displaced people and refugees in the region are living.

April 06, 2017

Less than a year after the official end of the Ebola outbreak, the Guinean health system continues to struggle.

March 27, 2017

First patent opposition MSF has filed in Europe aims to increase affordable access to hepatitis C drug sofosbuvir for millions

NEW YORK/ROME/GENEVA, MARCH 27, 2017—In an effort to increase access to affordable hepatitis C treatment, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) filed a patent challenge on the lifesaving hepatitis C drug sofosbuvir with the European Patent Office (EPO) today.

March 24, 2017

NEW YORK, MARCH 24, 2017—Today, World Tuberculosis Day, Doctors Without Borders/Médecins Sans Frontières’ (MSF) is urging pharmaceutical corporations, Sequella and Pfizer, to provide open access to all existing clinical data on a promising drug, sutezolid, to help accelerate the research and development of urgently needed new, lifesaving TB treatment regimes. This data, if not released, will take years and resources to replicate, further delaying new treatment options for people living with TB.

March 23, 2017

Companies and countries must take urgent action to increase access to these lifesaving treatments

February 14, 2017

NEW YORK/NEW DELHI, FEBRUARY 14, 2017—Five new challenges against flawed patents on crucial new medicines to treat hepatitis C filed in India and Argentina are the latest in a global push to ensure access to affordable treatment. The patent challenges could remove barriers to production and distribution of affordable generic versions of direct-acting antiviral (DAA) medicines, including sofosbuvir, daclatasvir and velpatasvir, and increase access for millions of people.

February 08, 2017

NEW YORK/N’AJAMENA, CHAD, FEBRUARY 9, 2017—A hepatitis E outbreak is escalating across Am Timan, in the Salamat region of South-Eastern Chad, and more humanitarian actors are urgently needed to treat patients and contain further spread of the virus, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) said today.

January 25, 2017

NEW YORK, JANUARY 25, 2017—The reinstatement of the US government’s Mexico City Policy by President Donald J. Trump, which prohibits nongovernmental organizations that receive US funding from either performing or providing counseling or information on abortion, will undermine access to safe abortion services and endanger the lives of women, said Doctors Without Borders/Médecins Sans Frontières (MSF) Wednesday.

January 24, 2017

While deal marks a critical step in the fight against TB, health groups warn that the deal lacks safeguards that would ensure worldwide affordability

January 19, 2017

NEW YORK, JANUARY 20, 2017—The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) began a new clinical trial this week in Uzbekistan to develop a radically improved course of treatment for drug-resistant tuberculosis (DR-TB).

The trial aims to find a treatment regimen for DR-TB that is drastically shorter, more effective, and causes fewer side effects than the current treatment options.

Pages